Funds and ETFs Morepen Laboratories Limited

Equities

MOREPENLAB

INE083A01026

Pharmaceuticals

Market Closed - Bombay S.E. 06:20:50 2024-04-30 am EDT 5-day change 1st Jan Change
50.03 INR -1.11% Intraday chart for Morepen Laboratories Limited -3.49% +3.09%

ETFs positioned on Morepen Laboratories Limited

Name Weight AuM 1st Jan change Investor Rating
0.00% 117 M€ -0.05% -
Morepen Laboratories Limited is a pharmaceutical company. The Company is in the business of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), branded and generic formulations and also home health products. Its APIs include Apixaban, Edoxaban, Linagliptin, Linagliptin + Metformin, Empagliflozin, Empagliflozin + Metformin, Atorvastatin, Rosuvastain, Rivaroxaban, Febuxostat, Montelukast (Oral), Montelukast (Chewable), among others. Its finished formulations include Intebact Capsules, Intelicaps Lax, Rythmix Kid Drop, Rythmix Kid Syrup, Kompact Powder, Saltum and Acifix 3X Suspension among others. Its home health products include Dr. Morepen 49W Room Air Purifier with HEPA Filter, Dr. Morepen VP06 Breathe Free Vaporizer, Dr. Morepen CN06 Compressor Nebulizer and Dr. Morepen ST03 Dual Head Stethoscope, among others. Its subsidiaries include Dr. Morepen Limited, Morepen Devices Limited, and Total Care Limited.
More about the company
  1. Stock Market
  2. Equities
  3. MOREPENLAB Stock
  4. Funds and ETFs Morepen Laboratories Limited